EUDR Connect 2024

WELCOME TO EUDR CONNECT 2024

The countdown is on! On December 30, 2024, the European Union’s Deforestation Regulation (EUDR) will replace the European Timber Regulation (EUTR), expanding to include more commodities like wood, palm oil, soy, cocoa, coffee, cattle, and rubber. This marks a critical juncture for industries, imposing stringent requirements to ensure deforestation-free supply chains. With potential penalties of at least 4% of EU turnover and significant reputational damage for non-compliance, ensuring compliance is imperative.

Join us at EUDR Connect on 3rd December to engage with regulatory authorities, industry leaders, and solution experts to drive compliance and innovation. Immerse yourself in an environment where ideas are shared, partnerships are formed, and actionable strategies are developed to meet the EUDR requirements and ensure a deforestation-free future.

Day

100+

Industry Experts

10+

Dedicated Networking Hours

Dedicated Workshops

WHY ATTEND?

Given the urgency and complexity of these new regulations, our event is designed to provide clear guidance, foster industry response, and explore innovative technological solutions to help companies navigate this challenging landscape effectively. Unlike other industry events, we focus specifically on the practical steps and new technologies that companies can adopt to comply with EUDR, ensuring that they are not only compliant but also leaders in sustainable practices. This event is timely and crucial for companies aiming to mitigate risks and capitalise on the opportunities presented by the EUDR.

REGISTER YOUR INTEREST

Gain Expert Insights Stay ahead of market trends and navigate regulatory challenges with guidance from industry experts.
Prepare Your Teams for EUDR Compliance: Get ready for the December 30th, 2024 deadline by training your teams on EUDR regulations, including upcoming inspection plans and customs requirements.
Conduct GAP Assessments: Identify where your industry currently falls short and learn how to effectively implement EUDR requirements within your supply chain.
Enhance Traceability and Due Diligence: Learn how to optimise your operations through improved traceability, impact assessments, and comprehensive due diligence practices.
Mitigate Risks: Develop strategies to manage both economic and reputational risks associated with non-compliance and industry changes.

CONNECT WITH SENIOR LEADERS FROM ACROSS THE SUPPLY CHAIN

SERIES ATTENDEES INCLUDE

HEALTH EQUITY SERIES SPEAKERS

Timshel Tarbet

Director Innovation Health Equity Accelerator

Providence Health Plan

Shannon Wilson

Vice President Population Health & Health Equity

Priority Health

Abdou Bah

Senior Vice President, Medical Management & Chief Health Equity Officer

Emblem Health

Lonie Haynes

SVP Chief Diversity, Health Equity, Inclusion and Justice Officer

Rochester Regional Health

Shiela Phicil

Director Innovation Health Equity Accelerator

Boston Medical Center

Tamira M. Moon

Director Health Equity and Diversity Initiatives, Association of State and Territorial Health Officials, CEO and Founder

To the Moon & Back Foundation, Inc.

SESSION HIGHLIGHTS INCLUDE:

Filter by:

All Topics

All Job Focuses

Printable version

Opening Presentation: European Commission: Current State of Play in The Industry? Trends and Expectations.

Interview to Answer Vital Industry Questions:

• What information do I need to report?

• What data do I need to report?

• Understand responsibility?

• What format do I report?

• Future planning and developments

Workshop: Understanding the Impact of EUDR on your Business

Join this deep dive workshop to discuss how to navigate the evolving policy and its impact on your organisation. Hear from a leading organisation who is on their way to being EUDR compliant.

Technology Innovation

Join this deep dive working group to discuss leveraging advanced technologies like satellite imagery, AI and blockchain to enhance supply chain transparency, monitor deforestation risks and provide actionable insights for sustainable sourcing.

OUR SELECTION COMITTEE

Author:

Brannon Morisoli

Director

SWK Holdings

Mr. Morisoli joined SWK Holdings as a Senior Analyst in March 2016. Prior to joining SWK, he was an Investment Analyst and Portfolio Manager for a family office that invested in equities, fixed income, real estate, and alternative investments. Prior to that, he was an Investment Analyst for Presidium Group, a real estate private equity firm, where he played an integral role in closing over $100mm in transactions. Mr. Morisoli began his career at Neurografix, a startup medical technology company in Santa Monica, CA that was doing groundbreaking work in the MRI imaging of peripheral nerves. While with Neurografix, he was published in two leading neurology journals. Brannon graduated from UCLA with a B.S., was awarded a fellowship and graduated from the University of Notre Dame with an M.B.A, and was awarded a Samson Fellowship from the University of Wisconsin Law School, where he graduated with a J.D. Mr. Morisoli is an inactive member of the State Bar of Wisconsin

Author:

Thomas Busby

Vice President

Outcome Capital

Thomas Busby is a Vice President and has been with Outcome Capital since 2015. He focuses on medical technology, digital health and life science services segments with particular interest in innovative life science companies that deliver patient impact by leveraging novel approaches. Thomas is driven by the desire to identify disruptive technologies and services that require unique strategic thought and assistance to realize their full market potential. Thomas has been published in leading life science journals Life Science Leader and The Pharma Letter, and also serves on the board of HealthTech Build, a Boston-based digital health innovation group.

Prior to his career in life-science investment banking, Thomas pursued his passion for the public service and non-profit sectors working in a variety of leadership and management positions, and at one time held a Massachusetts teaching license.

Thomas completed his MBA at Suffolk University’s Sawyer Business School on full academic scholarship where he was President of the school’s Graduate Business Association and class speaker at graduation. Prior, he completed a BS in Philosophy with Honors from Suffolk’s College of Arts & Sciences. Committed to giving back, Thomas is currently the President of the College of Arts & Sciences Alumni Board of Directors. Thomas is a FINRA Registered Securities Representative holding his Series 79 and 63.

Author:

Robert Crousore

Managing Partner

Health Frontier Ventures

Robert has 28 years of experience in the health care products and
services industry. Crousore is a serial entrepreneur with multiple
successful product and services company exits. His experience spans
the entire business enterprise including Sales, Marketing, Operations,
Product Innovation and, most recently M & A.

Highlights Include:

Has successfully managed a global commercial organization in the wound care business.
Has a number of patent credits for products in the wound care industry.
Sits on multiple boards of healthcare technology companies.
His passion is creating meaningful changes in patient care by combining great products with great teams that are focused on empowering improved clinical and financial outcomes.

Author:

Brannon Morisoli

Director

SWK Holdings

Author:

Thomas Busby

Vice President

Outcome Capital

Author:

Robert Crousore

Managing Partner

Health Frontier Ventures

Highlights Include:

Has successfully managed a global commercial organization in the wound care business.
Has a number of patent credits for products in the wound care industry.
Sits on multiple boards of healthcare technology companies.
His passion is creating meaningful changes in patient care by combining great products with great teams that are focused on empowering improved clinical and financial outcomes.

REGISTER YOUR INTEREST

Join the health equity community of pharmaceutical clin ops leaders, payers, and healthcare providers to unite and tackle healthcare inequities at every patient touchpoint. Be part of the change that ensures equitable access and quality care for all.

Why attend?

Drive community health initiatives to ensure preventative health with long lasting SDoH strategies and partnerships
Create data driven population health approaches to improve patient stratification
Ensure efficient health equity & SDoH functions through case studies from payers and providers

Jump to: Day 1 | Day 2

Printable version

Wednesday, 8 May, 2024

9:05am

The Importance of Health Equity and Social Determinants of Health (SDoH) in Payer Strategies.

Discover how health equity and SDoH have the potential to improve the financial situation for payers and reduce the financial burden on the health system through promoting preventative care, reducing emergency department visits and enhancing overall population health and ensure your compliance of the joint commissions accreditation standard.

Author:

Roslyn Moore

Deputy Director for Programs

Office of Minority Health

9:30am

Understanding the Financial Implications of Health Equity and SDoH for Payers and Ensuring ROI

Explore the financial impact of social determinants on healthcare costs and population health outcomes. Understand the role of payers in promoting the focus on health equity and the need of collaboration to implement the new strategies.

Author:

Lisa Porter

Director of Community Engagement Health Equity & Social Impact

Humana

Author:

Robyn Bussey

Director, Just Health

Partnership for Southern Equity

Thursday, 9 May, 2024

9:45 am

Improving Health Data Collection and Standardization in Health Equity and SDoH.

Uncover how we can move towards a standardisation of health data collection and use across states. Understanding how leaders utilise and collect health information, how we can Improve systems and data capture from a state community and zip code level.

Author: